Trelegy Ellipta is used to treat moderate to severe chronic obstructive pulmonary disease (COPD) or asthma. COPD is a group of diseases that affect your lungs and airways, causing breathing difficulties. The 2 main types of COPD are emphysema and chronic bronchitis. Learn more about COPD and medicines for COPD.
Trelegy Ellipta contains 3 medicines (fluticasone, umeclidinium and vilanterol) mixed together in 1 inhaler.
- Fluticasone prevents swelling and irritation in the walls of the small air passages in your lungs. It belongs to a group of medicines known as inhaled corticosteroids.
- Umeclidinium and vilanterol work together to relax the muscles in your airways. This helps to open your airways and makes it easier for airflow in and out of your lungs. When taken regularly, they help your airways to remain open.
Having 3 medicines in a single inhaler means you only need to use 1 inhaler instead of 2 or 3. To work well, Trelegy Ellipta must be used once daily, every day.
- Trelegy Ellipta is a dry powder inhaler. The powder is inhaled through your mouth and the inhaler device enables the medicine to go straight into your airways when you breathe in.
- This means that your airways and lungs are treated, but very little of the medicine gets to the rest of your body.
- From 1 May 2024, Trelegy Ellipta is funded for people with moderate to severe COPD who are using 2 or 3 inhalers daily and meet other criteria. Talk to your healthcare provider to see if Trelegy Ellipta is suitable for you.
- Note: Trelegy Ellipta inhaler comes in 2 strengths but only the lower strength is funded. This is fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcg which is the strength used for COPD.
Trelegy Ellipta doesn't give immediate relief from wheezing, tight chest and shortness of breathTo treat these symptoms, use your ‘reliever’ medicine, eg, salbutamol (Respigen, SalAir, Ventolin) or terbutaline (Bricanyl Turbuhaler). |